What Protara Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 3 |
| Total trades | 0 | 23 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 422,187 |
| Disposed | 0 | 320,696 |
| Net activity | +0 | +101,491 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Shefferman Jesse | CEO and President | Jun 30 | Gift · G | −5,000 | — | — | 691,832 |
| Shefferman Jesse | CEO and President | Jun 30 | Gift · G | −4,000 | — | — | 696,832 |
| Shefferman Jesse | CEO and President | Jun 30 | Gift · G | −7,000 | — | — | 700,832 |
| Shefferman Jesse | CEO and President | Jun 30 | Gift · G | −14,000 | — | — | 707,832 |
| Shefferman Jesse | CEO and President | Jun 29 | Open-market sale · S | −215,687 | $4.09 | −$882K | 721,832 |
| Shefferman Jesse | CEO and President | Jun 29 | Exercise / conversion · M | +215,687 | $1.91 | +$412K | 937,519 |
| Conkling William | Chief Commercial Officer | Jun 02 | Withheld — tax / exercise cost · F | −6,008 | $4.34 | −$26.1K | 69,992 |
| Zummo Jacqueline | Chief R&D Officer | Apr 08 | Disclosed 10b5-1 sale · S | −1,134 | $5.40 | −$6.12K | 94,827 |
| Zummo Jacqueline | Chief R&D Officer | Apr 01 | Disclosed 10b5-1 sale · S | −22,598 | $5.26 | −$119K | 95,961 |
| Fry Hannah | VP, Controller | Jan 26 | Withheld — tax / exercise cost · F | −1,457 | $6.67 | −$9.72K | 42,723 |
| Zummo Jacqueline | Chf Scientific Operations Off | Jan 26 | Withheld — tax / exercise cost · F | −3,724 | $6.67 | −$24.8K | 118,559 |
| Shefferman Jesse | CEO and President | Jan 26 | Withheld — tax / exercise cost · F | −8,732 | $6.67 | −$58.2K | 1,021,832 |
| Fabbio Patrick | Chief Financial Officer | Jan 26 | Withheld — tax / exercise cost · F | −3,261 | $6.67 | −$21.8K | 64,115 |
| Fry Hannah | VP, Controller | Jan 20 | Withheld — tax / exercise cost · F | −2,132 | $5.60 | −$11.9K | 44,180 |
| Zummo Jacqueline | Chf Scientific Operations Off | Jan 20 | Withheld — tax / exercise cost · F | −6,578 | $5.60 | −$36.8K | 122,283 |
| Fabbio Patrick | Chief Financial Officer | Jan 20 | Withheld — tax / exercise cost · F | −3,063 | $5.60 | −$17.2K | 67,376 |
| Shefferman Jesse | CEO and President | Jan 20 | Withheld — tax / exercise cost · F | −16,322 | $5.60 | −$91.4K | 1,030,564 |
| Fry Hannah | VP, Controller | Jan 16 | Grant / award · A | +9,500 | — | — | 46,312 |
| Shefferman Jesse | CEO and President | Jan 16 | Grant / award · A | +87,000 | — | — | 1,046,886 |
| Zummo Jacqueline | Chf Scientific Operations Off | Jan 16 | Grant / award · A | +30,000 | — | — | 128,861 |
Loading...
